عنوان فارسی مقاله: |
کنترل کم خونی ناشی از سرطان با عوامل اریتروپوتئیک: بازنگری شواهدی برای افزایش کیفیت زندگی و نتایج بالینی |
عنوان انگلیسی مقاله: |
Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes |
پیشینه
مقدمه
مواد و روش ها
تأثیر کم خونی بر HRQOL
کم خونی و خستگی
درمان کم خونی مربوط به سرطان
درمان کم خونی با عوامل ارتیرو پوئتیک باعث بهبود HRQOL می شود
نتیجه گیری ها
کلمات کلیدی :
PDF]Practice Guidelines in Oncology - Cancer- and Treatment-Related ...iron.sabm.org/reference/nccn_anemia_guidelines.pdfPRODUCTS 1 - 6 - NCCN Cancer- and Chemotherapy-Induced Anemia Panel Members ...... J. Control of cancer-related anemia with erythropoietic agents: A ...[PDF]Cancer-related anemia - Turner Whitewww.turner-white.com/pdf/brm_Hem_V10P1.pdfcontrol over the design and production of all published materials, including ... Treatment of cancer-related anemia has been contro- versial. Previously, blood transfusion and erythropoiesis- stimulating agents (ESAs) were considered standard.Anemia in Cancer Patients - US Pharmacisthttps://www.uspharmacist.com/article/anemia-in-cancer-patientsNov 15, 2013 - Erythropoiesis-stimulating agents, iron supplementation, and red blood cell ... Anemia is a major cause of morbidity in patients with cancer, linked with ... Erythropoietin controls the maturation, differentiation, and survival of ...Searches related to Control of cancer-related anemia with erythropoietic agentserythropoiesis-stimulating agentsaranespprocriterythropoietinepo